The new crown detection is the recent attention is relatively high popularity track, but many stockholders do not know the new crown detection concept stock which, today wealth management gentleman for the stockholders friends combed out the new crown detection concept leading stocks list for your reference.
Myriad Medical (300760)
Shenzhen Myriad Biomedical Electronics Co., Ltd. is mainly engaged in the research and development of medical devices, manufacturing, marketing and services, the main products cover three major areas: life information and support, in vitro diagnostics and medical imaging. Headquartered in Shenzhen, China, the company has 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; 17 subsidiaries and more than 40 branches in China, forming a large globalized R&D, marketing and service network. In the fifth batch of excellent domestic medical equipment catalog announced in 2019, the company*** has 4 models of fully automatic urine workstations, 5 models of defibrillators, 8 models of laparoscopes, 7 models of syringe pumps, 6 models of infusion pumps, 6 models of portable infusion pumps and 2 models of infusion workstations selected.
Pepcid (301080)
Beijing Pepcid Bio-technology Co., Ltd. is a high-tech enterprise specializing in the provision of recombinant proteins and other key biological reagent products and technical services. The company's main products are recombinant proteins and testing services, as well as kits, antibodies, fillers, culture media and other related products.In May 2019, the company was awarded the honorary title of "China's Foreign Trade Export Pilot Index Sample Enterprises", and in March 2020, it was selected as a finalist of the Ministry of Science and Technology's advanced technological achievements in the prevention and control of the epidemic and innovative products. In October 2020, the company was awarded the top 20 high-tech high-growth enterprises in Yizhuang; in July 2020, the company was awarded the honorary title of "Specialized, Specialized, Specialized, Specialized and New" small and medium-sized enterprises in 2020 in Beijing.
ShuoShi Bio(688399)
Jiangsu ShuoShi Bio-technology Co., Ltd. focuses on the research and development, production and sales of in vitro diagnostic reagents, supporting testing instruments and other in vitro diagnostic products; the company's main products are nucleic acid molecular diagnostic reagents, nucleic acid purification reagents, dry chemical diagnostic reagents and immunological diagnostic reagents. The company's main products are nucleic acid molecular diagnostic reagents, nucleic acid purification reagents, dry chemical diagnostic reagents and immunologic diagnostic reagents. The company has developed a series of products covering a wide range of fields such as infectious disease detection, tumor screening, micro-ecological detection of female reproductive tract, etc., which are widely used in the fields of prevention and control of infectious diseases, clinical testing, large-scale population screening and eugenics management, etc., and the company's products have a strong competitive advantage in the corresponding market segments. Our products have a strong competitive advantage in the corresponding market segments. The company is in a leading position in the field of molecular diagnostics.
Rui Zhi Pharmaceuticals (300149)
Rui Zhi Pharmaceuticals Science and Technology Co., Ltd.'s main business consists of two major business segments, respectively, pharmaceutical R & D and production services (CRO/CDMO), micro-ecology, nutrition and health care. Pharmaceutical R&D and production services (CRO/CDMO) segment as the company's core business segment, according to the nature of business, pharmaceutical R&D and production services (CRO/CDMO) segment business by the chemical CRO, biological CRO, small molecule CDMO, large molecule CDMO four major service modules. The company's micro-ecological health segment mainly focuses on the production of oligofructose and oligogalactose series of prebiotic products. The company is one of the few leading brands in China that possesses the full-process service capabilities of preclinical CRO (pharmaceutical R&D services) and CMO (pharmaceutical manufacturing services), and is among the top three in the preclinical CRO market.
Golden Med (603882)
Guangzhou Golden Med (603882) Inspection Group Co., Ltd. is a third-party medical testing and pathology diagnostic business as the core of high-tech service enterprises, is committed to providing medical testing and diagnostic information for medical institutions at all levels of the country to provide international standards of medical testing and diagnostic information integration services. The main services provided by the company are as follows: medical testing and diagnostic pathology, non-medical testing, reagent sales, reagent production, testing information services, medical cold chain logistics. Guangzhou Goldcorp was recognized for the first time as a "National Intellectual Property Model Enterprise", the highest honor in national intellectual property management. The company's quality management system covers ISO/IEC17025, ISO9001, ISO15189, CMA, CAP-LAP and so on.
New Open Source (300109)
Boai New Open Source (300109) Medical Technology Group Co., Ltd.'s main business includes fine chemicals and precision medicine. The main production products of the fine chemical business are: polyvinylpyrrolidone (PVP) series and related intermediates, vinyl methyl ether/maleic anhydride*** polymers (PVM/MA, Oritz) and related intermediates, oral care related series, etc.. The main products/services of the precision medicine business are: tumor early screening with gene sequencing as the main technology platform, molecular diagnosis of women's diseases, individualized medical services, etc. In September 2009, the company was recognized as a "high-tech enterprise", Certificate No.: GR200941000051, valid for 3 years.
Novizen (688105)
Nanjing Novizen Bio-technology Co., Ltd.'s main business is to focus on the enzymes, antigens, antibodies and other functional proteins and polymers and organic materials for the research and development of technology and product development. The company's main products are biological reagents and in vitro diagnostic products. The company has established Jiangsu Engineering Research Center, Jiangsu Enterprise Technology Center, Jiangsu Postdoctoral Innovation and Practice Base, and has undertaken a number of provincial and municipal major special projects and special funds, such as Jiangsu Science and Technology Department of Science and Technology Transformation Special Project, Jiangsu Industry and Information Technology Department of Jiangsu Province, Key Areas of *** Sexual Technology Tackling Project, Jiangsu Development and Reform Commission of Nucleic Acid Detection Reagents and Vaccine Drugs Production and R & D Enterprises, and has won the honor of "Small Giant Enterprise of Science and Technology of Jiangsu Province, Service Enterprise of Jiangsu Province". Science and technology small giant enterprises, Jiangsu Province, service-oriented manufacturing demonstration cultivation enterprises and Nanjing cultivation of unicorns and many other honorary titles.
Dian Diagnostics (300244)
Dian Diagnostics (300244) Technology Group Company Limited's main business is medical diagnostic services and in vitro diagnostic product sales. The company's main products and services are diagnostic services, diagnostic products, cold chain logistics, health checkups, and financial leasing. In terms of oncology discipline, the company continues to deepen the discipline construction and marketing force building in parallel, in September in the CSCO Academic Annual Meeting won the second place in the CSCO annual meeting of the best satellite meeting (genetic testing group). We have obtained three Class III registration certificates, one Class II registration certificate, 27 Class I filed products, and one Class III diagnostic product is currently in the registration process.
Huamei Testing (300012)
Huamei Testing (300012) Certification Group Co. Ltd. a set of testing, calibration, inspection, certification and technical services as one of the integrated third-party organizations, to provide one-stop solutions on a global scale. The company's main services are food, agriculture and health products services, environmental testing services, medical and health services, construction engineering and industrial services, metrology and digitalization services, consumer goods services, automotive industry chain services, electronic technology services. The company is one of the earliest and most invested professional research institutes established by private testing organizations in China, and has set up a group research institute, relying on the technical support of the research institute to continuously improve the company's core competitiveness in the field of testing technology, with industry experts as the core of the R & D team dedicated to the study of cutting-edge technology in the industry, to provide strong technical support for the expansion of the business of the major divisions to obtain adequate technical preparation.
Guang Shengtang (300436)
Fujian Guangshengtang (300436) Pharmaceuticals Co., Ltd.'s main business is the research and development, production and sales of nucleoside anti-hepatitis B virus drugs; the company's main products are anti-hepatitis B virus drugs, hepatoprotective and liver-protecting drugs, drugs for the digestive system, respiratory drugs, cardiovascular drugs, medical testing services. The main products of the company are anti-hepatitis B virus drugs, hepatoprotective drugs, digestive system drugs, respiratory system drugs, cardiovascular drugs, and medical testing services; the company is currently a domestic pharmaceutical enterprise focusing on the field of liver health, and it is the only pharmaceutical enterprise in China that owns four major clinically preferred anti-hepatitis B virus drugs, namely, adefovir, lamivudine, entecavir, and tenofovir, simultaneously.